SCOPUS 정보 검색 플랫폼

International Journal of Antimicrobial Agents

Volumn 16, Issue 2, 2000, Pages 117-121

Colony stimulating factors in patients with fever and neutropenia

(1) Rubenstein, Edward B a

a UNIVERSITY OF TEXAS (United States)

Author keywords

Colony stimulating factors; Fever; Hematopoietic system; Neutropenia

Indexed keywords

AMIKACIN; AMPHOTERICIN; ANTINEOPLASTIC AGENT; CEFTAZIDIME; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUCLOXACILLIN; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NETILMICIN; PIPERACILLIN; RECOMBINANT INTERLEUKIN 11; TIMENTIN; TOBRAMYCIN;

ARTICLE; BONE MARROW SUPPRESSION; CANCER; FEBRILE NEUTROPENIA; FEVER; HEMATOPOIETIC SYSTEM; HUMAN; INFECTION; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIBIOTICS; CLINICAL TRIALS; COLONY-STIMULATING FACTORS; DRUG THERAPY, COMBINATION; FEVER; HUMAN; INFECTION; MIDDLE AGE; NEOPLASMS; NEUTROPENIA;

EID: 0033774153 PISSN: 09248579 EISSN: None Source Type: Journal
DOI: 10.1016/S0924-8579(00)00214-4 Document Type: Article

Times cited : (19)

References (26)

1
- 0007476261
- Wingard J, Demetri G. Clinical applications of cytokines and growth factors. In: Wingard JR, Demith GD, editors. Clinical Applications of Cytokines and Growth Factors, Norwell, MA: Kluwer Academic Publishers, 1998, p. xi.

2
- 0023682969
- Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression
- (1988) N. Engl. J. Med. , vol.319 , pp. 593-598
- Antman, K.¹ Griffin, J.² Anaissie, E.³

3
- 0023871477
- Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy
- (1988) Lancet , vol.1 , pp. 667-672
- Morstyn, G.¹ Campbell, L.² Souza, L.M.³

4
- 0025800331
- Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
- (1991) N. Engl. J. Med. , vol.325 , pp. 164-170
- Crawford, J.¹ Ozer, H.² Stoller, R.³

5
- 0027390482
- Recombinant granulocyte colonystimulating factor reduces the infectious complications of cytotoxic chemotherapy
- (1993) Eur. J. Cancer , vol.29 A , Issue.3 , pp. 319-324
- Trillet-Lenoir, V.¹ Green, J.² Manegold, C.³

6
- 0027183646
- A prospective evaluation of the activity of human granulocyte colony-stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma
- (1993) J. Chem. , vol.5 , Issue.3 , pp. 186-190
- Gebbia, V.¹ Testa, A.² Valenza, R.³

7
- 0026667676
- Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial
- (1992) Blood , vol.80 , Issue.6 , pp. 1430-1436
- Pettengell, R.¹ Gumey, H.² Radford, J.A.³

8
- 0001557549
- Granulocyte-macrophage colonystimulating factor (GM-CSF) in small cell carcinoma of the lung (SCCL): preliminaryanalysis of a randomized controlled trial (Abstract)
- (1991) Proc. Am. Soc. Clin. Oncol. , vol.10 , pp. 255
- Hamm, J.T.¹ Schiller, J.H.² Oken, M.M.³

9
- 0007476665
- VIP chemotherapy with/without GM-CSF for poor risk, relapsed, or refractory germ cell turnors (GCT): preliminary analysis of a randomized controlled trial (Abstract)
- (1991) Proc. Am. Soc. Clin. Oncol. , vol.10 , pp. 167
- Nichols, C.¹ Bajorin, D.² Schmoll, H.J.³

10
- 0027517297
- Randomized, double-blind, placebo-controlled Phase III study of recombinant human granulocyte-macrophage colonystimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas (Abstract)
- (1993) Blood , vol.82 , pp. 2329-2339
- Gerhartz, H.H.¹ Engelhard, M.² Meusers, P.³

11
- 0007560704
- Bunn PA, Crowley J, Hazuka M, et al. The role of GM-CSF in limited stage SCLC: A randomized phase Ill study of the Southwest Oncology Group (SWOG) (Abstract). Proc. Am. Soc. Clin. Oncol. 11:292, 1992.

12
- 0029015209
- A randomized placebo-controlled Phase Ill study of granulocyte-macrophage colony-stimulating factor in adult patients (>55-70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)
- (1995) Blood , vol.86 , Issue.2 , pp. 457-462
- Rowe, J.M.¹ Andersen, J.W.² Mazza, J.J.³

13
- 0029012359
- Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors
- (1995) J. Natl. Cancer Inst. , vol.87 , pp. 803-808
- Mayordomo, J.I.¹

14
- 0028580535
- Filgrastim in patients with chemotherapy-induced febrile neutropenia: a double-blind, placebo-controlled trial
- (1995) Ann. Intern. Med. , vol.121 , pp. 492-501
- Maher, D.W.¹

15
- 0029979048
- Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia
- (1996) Anti-Cancer Drugs , vol.7 , pp. 392-397
- Aviles, A.¹ Guzman, R.² Garcia, E.L.³

16
- 0031044740
- Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients
- (1997) J. Clin. Oncol. , vol.15 , Issue.3 , pp. 1163-1170
- Mitchell, P.L.I.R.¹ Morland, B.² Stevens, M.C.G.³

17
- 0030058402
- Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia
- (1996) Am. J. Med. , vol.100 , pp. 17-23
- Anaissie, E.J.¹ Vartivarian, S.² Bodey, G.P.³

18
- 0007556683
- Elting LS, Rubenstein EB, Rolston K, Bodey GP. Correlation between antibiotic regimen and duration of fever in gram negative bacteremias (GNB). Seventh International Symposium Supportive Cancer in Cancer 1995, September 20-23, Luxembourg.

19
- 0007555244
- Elting LS, Rubenstein EB, Rolston KM, Bodey GP. Outcomes of bacteremia in neutropenic cancer patients: observations from two decades of epidemiologic and clinical trials, Clin Infect Dis 1997;25(2):247-59.

20
- 0007517656
- American Society of Clinical Oncology Ad Hoc Colony-Stimulating Factor Guidelines Expert Panel. American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines, J Clin Oncol 1994;12(11):2471-508.

21
- 0027407999
- Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy
- (1993) J. Natl. Cancer Inst. , vol.85 , Issue.6 , pp. 488-493
- Lyman, G.H.¹ Lyman, C.G.² Sanderson, A.³

22
- 0027300930
- Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
- (1993) Cancer , vol.71 , Issue.11 , pp. 3640-3646
- Rubenstein, E.B.¹ Rolston, K.² Benjamin, R.S.³

23
- 0033615008
- A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
- (1999) N. Engl. J. Med. , vol.341 , Issue.5 , pp. 305-311
- Freifeld, A.¹ Marchigiani, D.² Walsh, T.³

24
- 0007476666
- Kem WV, Cometta A, DeBock R, Langenaeken J, Paesmans M, Gaya H for the International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy, N Engl J Med 1999;341(5):312-8.

25
- 0028934175
- Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial
- (1995) Am. J. Med. , vol.98 , pp. 224-231
- Malik, I.A.¹ Khan, W.A.² Karim, M.³

26
- 0007516583
- The Philadelphia Intergroup Study (PBT-1). Phase III randomized trial of high-dose chemotherapy (HDC) and stem cell support (SCT) shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracill (CMF) for women with metastatic breast cancer who are responding to conventional induction chemotherapy (Abstract)
- (1999) Prog./Proc. Am. Soc. Clin. Oncol. , vol.18 , pp. 185
- Stadtmauer, E.A.¹ O'Neill, A.² Goldstein, U.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.